A Reduction-responsive Amphiphilic Methotrexate-Podophyllotoxin Conjugate for Targeted Chemotherapy

© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim..

Owing to the naturally high toxicity, poor water solubility, and other side effects of podophyllotoxin (PPT), its applications are limited. To address these issues, we developed a new PPT delivery system, in which the hydrophilic drug methotrexate (MTX) and the hydrophobic drug PPT were linked by a reduction-responsive disulfide bond to form an amphiphilic drug-drug conjugate prodrug (MTX-SS-PPT). The conjugate could self-assemble into spherical nanoaggregates in aqueous solution and self-deliver to tumor tissues. In addition, MTX could target to folate-receptor-positive cells. Over-expression of glutathione in tumor cells broke the disulfide bonds and released the free drug. In vitro and in vivo experiments indicated that the nanodrug could effectively improve the biocompatibility and reduce the toxicity of PPT.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:14

Enthalten in:

Chemistry, an Asian journal - 14(2019), 21 vom: 04. Nov., Seite 3840-3844

Sprache:

Englisch

Beteiligte Personen:

Hou, Meili [VerfasserIn]
Li, Shanshan [VerfasserIn]
Xu, Zhigang [VerfasserIn]
Li, Baosheng [VerfasserIn]

Links:

Volltext

Themen:

Amphiphilic molecules
Chemotherapy
Journal Article
Podophyllotoxin
Reduction-responsive
Target

Anmerkungen:

Date Completed 06.11.2019

Date Revised 08.01.2020

published: Print-Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.1002/asia.201901070

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM301605092